Wuhan Keqian Biology Co.,Ltd (688526.SS)
CNY 14.62
(-0.27%)
CNY 14.62
(-0.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 538.03 Million | 423.7 Million | 531.27 Million | 400.13 Million | 154.88 Million | 351.83 Million |
| Net Income | 395.58 Million | 409.14 Million | 570.63 Million | 447.8 Million | 242.64 Million | 388.91 Million |
| Depreciation & Amortization | 114.26 Million | 97.68 Million | 62.64 Million | 37.02 Million | 37.14 Million | 34.7 Million |
| Deferred income taxes | -17.36 Million | 16.63 Million | 16.16 Million | -297.98 Thousand | 2.94 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -13.25 Million | -64.32 Million | -63.29 Million | -61.07 Million | -101.22 Million | -49.41 Million |
| Other non-cash items | 41.44 Million | -18.8 Million | -38.71 Million | -23.62 Million | -23.67 Million | -22.36 Million |
| Investing Cash Flow | -328.99 Million | -637.12 Million | -331.1 Million | -1.19 Billion | -623.72 Million | 323.03 Million |
| Investments in PPE | -104.5 Million | -102.85 Million | -374.44 Million | -111.59 Million | -137.73 Million | -31.42 Million |
| Acquisitions | -4.05 Million | -8.46 Million | 545 Thousand | 111.62 Million | 137.73 Million | - |
| Investment purchases | -2.26 Billion | -1.43 Billion | -1.11 Billion | -1.78 Billion | -1.26 Billion | -1.2 Billion |
| Sales/Maturities of investments | 2.04 Billion | 913.85 Million | 1.15 Billion | 704.66 Million | 775.06 Million | 1.54 Billion |
| Other Investing Activities | 178.99 Thousand | 84.41 Thousand | -544.99 Thousand | -111.59 Million | -137.73 Million | 11.68 Million |
| Financing Cash Flow | -102.42 Million | 113.52 Million | -121.18 Million | 1.2 Billion | -85.75 Million | -120.71 Million |
| Debt repayment | -221.51 Million | -77.99 Million | -60.01 Million | -60 Million | - | - |
| Dividends payments | -88.57 Million | -88.37 Million | -134.85 Million | -368.95 Thousand | -85.75 Million | -122.27 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -20.32 Million | 284.99 Million | 75.64 Million | 1.26 Billion | -85.75 Million | 1.56 Million |
| Accounts receivables | -19.84 Million | -134.35 Million | -118.71 Million | -123.29 Million | -53.23 Million | -38.6 Million |
| Accounts payables | 15.15 Million | 121.35 Million | 77.76 Million | 72.54 Million | -58.01 Million | - |
| Inventory | 8.8 Million | -67.96 Million | -38.49 Million | -10.02 Million | 7.07 Million | -11.88 Million |
| Other working capital | -17.36 Million | 16.63 Million | 16.16 Million | -297.98 Thousand | 2.94 Million | -37.52 Million |
| Cash at beginning of period | 450.7 Million | 550.59 Million | 471.6 Million | 56.04 Million | 610.62 Million | 56.48 Million |
| Cash at end of period | 557.36 Million | 450.7 Million | 550.59 Million | 471.6 Million | 56.04 Million | 610.62 Million |
| Capital Expenditure | -104.5 Million | -102.85 Million | -374.44 Million | -111.59 Million | -137.73 Million | -31.42 Million |
| Effect of forex changes on cash | 54.93 Thousand | 1.11 | -0.07 | - | 0.28 | 0.62 |
| Net cash flow / Change in cash | 106.66 Million | -99.89 Million | 78.98 Million | 415.56 Million | -554.58 Million | 554.14 Million |
| Free Cash Flow | 433.52 Million | 320.85 Million | 156.82 Million | 288.54 Million | 17.15 Million | 320.41 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 107.99 Million | 65.38 Million | 87.22 Million | 38.5 Million | 395.58 Million | 118.26 Million |
| Depreciation & Amortization | - | 27.08 Million | 27.08 Million | 28.14 Million | 114.26 Million | -58.2 Million |
| Deferred income taxes | 1.74 Million | - | - | - | -17.36 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 387.48 Million | - | -11.04 Million | -13.25 Million | 12 Million |
| Other non-cash items | 13.1 Million | 1.28 Million | 45.85 Million | 54.8 Million | 41.44 Million | 181.93 Million |
| Investing Cash Flow | -224.3 Million | 16.06 Million | 225.42 Million | -143.32 Million | -328.99 Million | 31.67 Million |
| Investments in PPE | -10.72 Million | -6.92 Million | -11.08 Million | -47.48 Million | -104.5 Million | -28.01 Million |
| Acquisitions | - | - | - | -3.87 Million | -4.05 Million | 0.09 |
| Investment purchases | -431 Million | -252.44 Million | -194.06 Million | -1.21 Billion | -2.26 Billion | -329.12 Million |
| Sales/Maturities of investments | 218.92 Million | 259.82 Million | 446.18 Million | 1.12 Billion | 2.04 Billion | 388.81 Million |
| Other Investing Activities | -1.5 Million | 15.61 Million | -15.61 Million | -0.43 | 178.99 Thousand | - |
| Financing Cash Flow | -182.39 Million | -155.41 Million | -127.42 Million | -47.36 Million | -102.42 Million | -11.88 Million |
| Debt repayment | -174.98 Million | -46.99 Million | -101.5 Million | -3.49 Million | -221.51 Million | -105 Million |
| Dividends payments | -1.24 Million | -201.15 Million | -1.94 Million | -88.57 Million | -88.57 Million | -1.74 Million |
| Common Stock Repurchased | 24.9 Million | -24.9 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -6.16 Million | -177.17 Million | -23.98 Million | -19.75 Million | -20.32 Million | 94.86 Million |
| Accounts receivables | - | 386.02 Million | - | -19.84 Million | -19.84 Million | 15.51 Million |
| Accounts payables | - | - | - | - | 15.15 Million | - |
| Inventory | - | 1.46 Million | - | 8.8 Million | 8.8 Million | -3.5 Million |
| Other working capital | - | - | - | - | -17.36 Million | - |
| Cash at beginning of period | 688.69 Million | 800.29 Million | 557.36 Million | 655.61 Million | 450.7 Million | 411.63 Million |
| Cash at end of period | 393.5 Million | 688.95 Million | 788.45 Million | 557.36 Million | 557.36 Million | 655.61 Million |
| Capital Expenditure | -10.72 Million | -6.92 Million | -11.08 Million | -47.48 Million | -104.5 Million | -28.01 Million |
| Effect of forex changes on cash | -9708.70 | -1830.12 | 0.06 | -17.96 Million | 54.93 Thousand | -29.81 Million |
| Net cash flow / Change in cash | -295.18 Million | -111.33 Million | 231.09 Million | -98.24 Million | 106.66 Million | 243.97 Million |
| Free Cash Flow | 112.11 Million | 32.65 Million | 122 Million | 62.93 Million | 433.52 Million | 225.98 Million |
000695
MARI
SMFIL
SHECF
KARN
SEFER